Who has been buying Phampsin stock?

0 distinct insiders have filed 0 disclosed insider purchases in Phampsin (208340), most recently on 2024-09-27. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Phampsin have?

Phampsin has 0 buy-side and 0 sell-side disclosures on record, spanning 2023-12-26 to 2024-09-27.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Phampsin 208340

Company

파멥신Phampsin

Insiders

Buys

Total Value

—

Avg Return

—

Last Filing

2024-09-27

Phampsin (208340) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Phampsin is dated 2023-12-26; the most recent is 2024-09-27.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2024-09-27	SELL	임원퇴임	김재현 Jaehyun Kim	moving	-42.9K	₩2,915	+96.0%	₩125M ($87K)
2024-09-27	SELL	임원퇴임	이정일 Lee Jeong-il	moving	-28.6K	₩2,915	+96.0%	₩83M ($58K)
2024-09-27	SELL	임원퇴임	한병재 Byeongjae Han	moving	-57.1K	₩2,915	+96.0%	₩167M ($116K)
2024-07-23	BUY	제3자배정유상증자	김정규 Kim Jeong-gyu	CEO	12.2M	₩2,915	-96.0%	₩35.6B ($24.8M)
2024-07-23	BUY	유상신주취득	심주엽 Shim Joo-yeop	-	11.0M	₩2,915	-96.0%	₩32.1B ($22.3M)
2024-07-17	BUY	유상신주취득	임현묵 Lim Hyun-mook	thanks	71.4K	₩2,915	-96.0%	₩208M ($145K)
2024-07-17	BUY	유상신주취득	맹필재 Maeng Piljae	moving	28.6K	₩2,915	-96.0%	₩83M ($58K)
2024-07-17	BUY	유상신주취득	한병재 Byeongjae Han	moving	57.1K	₩2,915	-96.0%	₩167M ($116K)
2024-07-17	BUY	유상신주취득	김재현 Jaehyun Kim	moving	42.9K	₩2,915	-96.0%	₩125M ($87K)
2024-07-17	BUY	제3자배정유상증자	김정규 Kim Jeong-gyu	CEO	1.0M	₩2,915	-96.0%	₩2.9B ($2.0M)
2024-07-17	BUY	유상신주취득	이정일 Lee Jeong-il	moving	28.6K	₩2,915	-96.0%	₩83M ($58K)
2024-07-17	BUY	유상신주취득	이원섭 Wonseop Lee	Managing Director	71.4K	₩2,915	-96.0%	₩208M ($145K)
2024-07-17	BUY	유상신주취득	유진산 Yujin Mountain	vice president	142.9K	₩2,915	-96.0%	₩416M ($289K)
2024-06-28	BUY	유상신주취득	심주엽 Shim Joo-yeop	-	3.3M	₩2,915	-96.0%	₩9.6B ($6.7M)
2024-01-29	BUY	신규선임	맹필재 Maeng Piljae	moving	42.8K	₩2,915	-96.0%	₩125M ($87K)
2023-12-26	BUY	유상신주취득	이원섭 Wonseop Lee	Managing Director	32.2K	₩3,930	-97.1%	₩126M ($88K)
2023-12-26	BUY	유상신주취득	유진산 Yujin Mountain	vice president	281.4K	₩3,930	-97.1%	₩1.1B ($768K)
2023-12-26	BUY	제3자배정유상증자	김정규 Kim Jeong-gyu	CEO	562.7K	₩3,930	-97.1%	₩2.2B ($1.5M)

Frequently asked questions

Who has been buying Phampsin stock?: 0 distinct insiders have filed 0 disclosed insider purchases in Phampsin (208340), most recently on 2024-09-27. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Phampsin have?: Phampsin has 0 buy-side and 0 sell-side disclosures on record, spanning 2023-12-26 to 2024-09-27.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.